[LGND] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 61.58%
YoY- 1,107.66%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 84,675 41,420 24,987 90,043 27,995 19,521 18,418 28.91%
PBT 33,301 28,119 -18,028 95,579 8,300 -9,644 22,292 6.91%
Tax 2,576 6,033 -3,609 22,419 2,242 -3,881 265 46.03%
NP 30,725 22,086 -14,419 73,160 6,058 -5,763 23,564 4.51%
Tax Rate -7.74% -21.46% - -23.46% -27.01% - -1.19% -
Total Cost 53,950 19,334 39,406 16,883 21,937 25,284 -5,146 -
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 36.29 53.32 -57.71 81.25 21.64 -29.52 127.94 -18.92%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS 1.84 1.38 -0.74 3.45 0.29 -0.28 1.19 7.52%
EPS Diluted 1.79 1.32 -0.74 2.99 0.26 -0.28 1.11 8.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.